25  Session 16: Regulatory Implications · Crisis Dynamics

Unit 3 — Decision and Application
Book Chapter 8 (all sections)
Track Common core (both tracks)
Assessment milestone PS2 due (start of class)

25.1 Learning Objectives

By the end of this session, students will be able to:

  1. Identify the major regulatory frameworks affecting private market valuation: Solvency II, AIFMD, IFRS 13, Basel III, GASB 72.
  2. Explain how each framework currently treats private market valuation and where GE-LAV would change the treatment.
  3. Apply the crisis amplification factor (4.31×) and explain what it represents.
  4. Discuss the Financial Stability Board (FSB) concerns about private markets and how GE-LAV addresses them.
  5. Connect correct private market valuation to systemic financial stability — and articulate why this is a regulator-relevant issue, not just an LP-level concern.

25.2 Pre-Class Assignment

  • Submit: PS2 (due at start of class)
  • Read: Book Chapter 8, all sections (~15 pages)

25.3 In-Class Outline (75 minutes)

Time Segment Format
0:00–0:05 PS2 collection · Why regulation matters Lecture
0:05–0:25 Solvency II — current treatment + GE-LAV alternative Lecture
0:25–0:40 AIFMD, IFRS 13, Basel III — survey Lecture
0:40–0:55 Crisis amplification mechanics — the 4.31× factor Lecture + chart
0:55–1:10 Systemic implications: FSB concerns Lecture
1:10–1:15 Discussion: should GE-LAV be mandatory? Discussion

25.4 Discussion Questions

  1. The 2024 SEC private fund advisor rule increased disclosure requirements for private market funds. Is this a step toward GE-LAV adoption, or orthogonal to it? What additional disclosure would GE-LAV require?
  2. If GE-LAV’s crisis amplification factor (4.31×) is correct, the 2008 PE losses were partly unmeasurable under DCF accounting. Should historical PE returns be retroactively restated? What are the institutional barriers?
  3. The Pigouvian exit tax (~6-8% at GFC depth) would have generated $5-15B in 2008. Where should that revenue go — back to the affected fund, the SIPC equivalent, the general fund? Who decides?

25.5 Worked Numerical Example: Solvency II Capital Charge

Scenario: A European insurer (Allianz-style) holds €5B in private equity (single-fund concentration). Need to compute SCR under three approaches.

Approach 1: Standard Solvency II - Type 2 equity (private) stress factor: -49% - SCR = €5B × 49% = €2.45B - Capital charge: €2.45B

Approach 2: GE-LAV at normal liquidity - LAV-adjusted NAV: €5B × (1 + 1.7% Jensen) = €5.085B (mild increase) - GE-LAV equilibrium rate at \(L = 0\): ~8.5% (vs. DCF 7.5%, so ~5% adjustment) - Adjusted NAV: ~€4.75B (after equilibrium correction) - SCR using same 49% on adjusted NAV: €2.33B - Capital charge: €2.33B (slight reduction)

Approach 3: GE-LAV stress test (GFC depth) - GE-LAV value at \(L = -1.5\): €5B × (1 - 0.70) = €1.5B - The stress drawdown to €1.5B exceeds Solvency II’s 49% stress floor - Stress-scenario capital required: €5B - €1.5B = €3.5B (significantly more than Solvency II)

Comparison: | Approach | Capital Charge | |—|—| | Solvency II standard | €2.45B | | GE-LAV normal | €2.33B | | GE-LAV stressed | €3.50B |

Interpretation: GE-LAV would reduce normal-state capital requirement by ~€120M, BUT under stress requires €1.05B more capital than Solvency II. Net effect depends on stress probability weighting.

25.6 What to Expect Next Session

Session 17 begins the implementation and platform topic (book Ch. 9). We’ll dive into how GE-LAV is operationalized:

  • The GE-LAV® platform architecture
  • Data inputs and calibration workflow
  • The valuation pipeline: from raw data to portfolio diagnostics
  • Validation against historical stress episodes

Reading: Book Chapter 9, sections 9.1–9.5 (~12 pages).


← Session 15 | Schedule | Next: Session 17 →